Leo Rasche
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 102
- Oncology top 2%
- CAR-T cell therapy research 32
- Peptidase Inhibition and Analysis 22
- Cancer Treatment and Pharmacology 11
- Immunology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 24
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 36
-
- Chronic Lymphocytic Leukemia Research 9
-
- Lymphoma Diagnosis and Treatment 9
- Co-authors
- Hermann EinseleK. Martin KortümNiels WeinholdJohannes DuellAndreas RosenwaldMax S. ToppStefan KnopGareth J. Morgan
- Cited by
- HematologyOncologyImmunology
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Leo Rasche
122 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Hematology 1.3k
- Oncology 1.3k
- Immunology 394
- Radiology, Nuclear Medicine and Imaging 368
- Molecular Biology 1.1k
Countries citing papers authored by Leo Rasche
This map shows the geographic impact of Leo Rasche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Rasche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Rasche more than expected).
Fields of papers citing papers by Leo Rasche
This network shows the impact of papers produced by Leo Rasche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Rasche. The network helps show where Leo Rasche may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leo Rasche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 9 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 25 | |
| 12 | 2023 | 1 | |
| 13 | 2021 | 43 | |
| 14 | 2019 | 8 | |
| 15 | 2019 | 41 | |
| 16 | 2017 | 2 | |
| 17 | 2017 | 8 | |
| 18 | 2016 | 47 | |
| 19 | 2015 | 62 | |
| 20 | 2008 | 15 |
About Leo Rasche
Leo Rasche is a scholar working on Hematology, Oncology and Genetics, having authored 140 papers that have together received 2.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (102 papers), Protein Degradation and Inhibitors (36 papers), CAR-T cell therapy research (32 papers), Monoclonal and Polyclonal Antibodies Research (24 papers), Peptidase Inhibition and Analysis (22 papers), Cancer Treatment and Pharmacology (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). The work is most often cited by research in Hematology (1.3k citations), Oncology (1.3k citations) and Immunology (394 citations). Leo Rasche has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Hermann Einsele, K. Martin Kortüm, Niels Weinhold, Johannes Duell, Andreas Rosenwald, Max S. Topp, Stefan Knop, Gareth J. Morgan, Markus Kapp and Stephan Mielke. Their work appears in journals such as Blood, Annals of Hematology, Leukemia, Cancers and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.